Shane Bohnen - 15 Aug 2023 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role
SVP - General Counsel
Signature
/s/ Shane Bohnen
Issuer symbol
TECH
Transactions as of
15 Aug 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
14 Dec 2023, 18:14:18 UTC
Date Of Original Report
17 Aug 2023
Previous filing
04 Apr 2023
Next filing
05 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Award $0 +4,802 $0.000000 4,802 15 Aug 2023 Common Stock 4,802 Direct F1, F2
transaction TECH Stock Option (Right to Buy) Award $0 +12,924 $0.000000 12,924 15 Aug 2023 Common Stock 12,924 $84.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Remarks:

This amendment is being filed to correct the number of restricted stock units and performance options being granted.